Initiation of antipsychotics after moving to residential aged care facilities and mortality: a national cohort study
Open Access
- 11 March 2020
- journal article
- research article
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 33 (1) , 95-104
Abstract
Background: There is a high burden of antipsychotic use in residential aged care facilities (RACFs) and there is concern regarding potential inappropriate prescribing of antipsychotics in response to mild behavioural symptoms. Antipsychotic use has been associated with a higher risk of mortality in community-dwelling older adults with dementia, but few studies have examined associations upon RACF entry. Aims: To examine associations between incident antipsychotic use and risk of mortality for people with and without diagnosed dementia in RACFs. Methods: A retrospective cohort study, employing a new-user design (individuals did not receive an antipsychotic 6 months before enrolment) of 265,820 people who accessed RACFs in Australia between 1/4/2008 and 30/6/2015 was conducted. Cox regression models were used to examine adjusted associations between antipsychotic use in the first 100 days of RACF entry and mortality. Results: In the 100 days after entering care, 29,455 residents (11.1%) were dispensed an antipsychotic. 180,956 (68.1%) residents died [38,249 (14.4%) were related to cerebrovascular causes] over a median 2.1 years (interquartile range 1.0–3.6) follow-up. Of the residents included, 119,665 (45.0%) had a diagnosis of dementia. Incident antipsychotic use was associated with higher risk of mortality in residents with dementia (adjusted hazard ratio 1.20, 95% confidence interval 1.18–1.22) and without dementia (1.28, 1.24–1.31). Conclusion: Initiation of antipsychotics after moving to RACFs is associated with a higher risk of mortality. Careful consideration of the potential benefits and harms should be given when starting a new prescription for antipsychotics for people moving to RACFs.Keywords
Funding Information
- Department of Innovation and Skills
This publication has 35 references indexed in Scilit:
- Living well in care homes: a systematic review of qualitative studiesAge and Ageing, 2012
- Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-ADAmerican Journal of Psychiatry, 2011
- Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homesCanadian Medical Association Journal, 2011
- Impact of FDA Black Box Advisory on Antipsychotic Medication UseArchives of internal medicine (1960), 2010
- All-Cause Mortality Associated With Atypical and Conventional Antipsychotics Among Nursing Home Residents With DementiaThe Journal of Clinical Psychiatry, 2009
- The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trialThe Lancet Neurology, 2009
- Use of antipsychotics in elderly patients with dementia: Do atypical and conventional agents have a similar safety profile?Pharmacological Research, 2009
- Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic MedicationsNew England Journal of Medicine, 2005
- Evaluating Medication Effects Outside of Clinical Trials: New-User DesignsAmerican Journal of Epidemiology, 2003
- Construction and Characteristics of the RxRisk-VMedical Care, 2003